Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Working Capital Changes: 2022-2025

Historic Other Working Capital Changes for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to $60,037.

  • bioAffinity Technologies' Other Working Capital Changes fell 67.77% to $60,037 in Q3 2025 from the same period last year, while for Sep 2025 it was $13,299, marking a year-over-year decrease of 78.20%. This contributed to the annual value of $105,594 for FY2024, which is 149.25% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Other Working Capital Changes is $60,037, which was up 358.11% from -$23,260 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Other Working Capital Changes ranged from a high of $530,481 in Q3 2022 and a low of -$161,445 during Q2 2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$17,032 (2024), whereas its average is -$7,134.
  • In the last 5 years, bioAffinity Technologies' Other Working Capital Changes tumbled by 840.77% in 2023 and then soared by 126.58% in 2024.
  • bioAffinity Technologies' Other Working Capital Changes (Quarterly) stood at -$9,424 in 2022, then tumbled by 554.01% to -$61,634 in 2023, then surged by 72.37% to -$17,032 in 2024, then tumbled by 67.77% to $60,037 in 2025.
  • Its Other Working Capital Changes stands at $60,037 for Q3 2025, versus -$23,260 for Q2 2025 and -$6,446 for Q1 2025.